Ethical Standards in Healthcare Product Promotion in South Africa
26 March 2013,
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Marketing Code Authority (MCA) hosted a joint event to highlight the standards of healthcare product promotion in South Africa and globally. The event was organized to raise awareness of industry self-regulatory codes, including the revised IFPMA Code of Practice. During this interactive meeting, which was attended by over 100 participants, representatives from government, trade associations, healthcare professional bodies, healthcare companies, and academia provided their insights on ethical promotion of healthcare products.
The focus of the meeting was on the interactions between the healthcare industry and healthcare professionals as the relationship between the two is essential for ensuring appropriate use of healthcare products. During the meeting, it was stressed that ethical and responsible promotion of healthcare products requires commitment from both healthcare professionals and the industry which is essential for patient health and safety.
IFPMA and the South Africa MCA believe that it is important for all healthcare stakeholders to collaborate to ensure that patients receive the best available treatments and care. The meeting also provided the MCA with insights and experiences from various healthcare stakeholders to help implement the MCA’s Code of Marketing Practice and Operating Procedure in a manner that balances the concerns of all affected parties. The event concluded with general agreement that cooperation among multiple stakeholders is required in order to establish a sustainable ethical business environment and to ensure best available healthcare for patients.
- Program & Speaker Biography
- Presentation: Russel Williams (Rx&D Canada / IFPMA)
- Presentation: Gavin Steel (Department of Health, South Africa)
- Presentation: Roy Jobson (Rhodes University)
- Presentation: Laurenne James (Aspen Pharmacare)
- Presentation: Heather Simmonds (PMCPA)
- Presentation: Chrisoula Nikidis (Rx&D Canada)
- Presentation: Roeland van Aelst (Johnson and Johnson)
- Presentation: Robert Skinner (GSK)